Editorial Policies

Focus and Scope

Trends in Immunotherapy is an open access, peer-reviewed journal encompassing various disciplines related to the immune-based therapeutic method. The journal covers all areas of immunotherapy including:

  1. Cancer immunotherapy
  2. Immunomodulators
  3. Antibodies
  4. Allergy disorder and immunotherapy
  5. Therapeutic method for auto-immune disorder
  6. Immunotherapy cell-products
  7. Cytokines application
  8. Immuno-modulatory effects of natural products

Preliminary studies, pre-clinical and clinical investigative reports are welcomed. The journal accepts original research article, review article, case reports and short communications.

 

Section Policies

Editorial

Editorial reflects the opinion of an Editorial Board member or staff for particular Journal highlighting recent changes, concerned issues or announcements in relevance to the journal. This may include editorial management and policies.

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Case Report

Case report is a detailed description on rare diseases, novel occurrences, unusual indication or symptoms of a disease, unreported studies or unexpected events observed in a patient during the course of treatment. The study should highlight and report new cases in diagnosis of emerging diseases or specify variations and associations with new diseases. Case report should contain educational values and emphasize on the need of amendments to usual practices and approaches in the field. Case reports should comprise different findings with updated review on previous cases and investigation in the field. There should not be any preventive and therapeutic intrusions in the Case reports from the findings since they need more confirmed evidences.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Commentary

Commentary is short account commissioned by the Editorial board and call for attention on the current issues confined to a particular subject area while sometimes unsolicited articles are accepted from contemporary scientists or experts in the field. The context is to analyze the issues of interest to readers or a discussion on current research and recently published articles in the Journal. Commentaries may also include editorial opinion relevant to scope of the Journal and discuss external implications such as new technology, grant applications, peer reviewing process on research.

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Correspondence Article

Correspondence article is letter addressed to the Editor with a short comment on topical issues or reader’s reaction corresponding to an informal publication previously published in the journal. Usually correspondences will not be peer reviewed and should not contain technical comments on research articles or principal research data.

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Database Article

Database article should contain vast biomedical information made available to wide utility, accessibility for the retrieval of data.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Mini-review

Mini-review is summarized descriptions based on one or more recent findings and significant developments at particular subject area of research considering the Journal’s scope. It is usually commissioned to create interest on the work and warrant further commentaries on the published articles. Maximum length is 2500 words.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Original Research Article

Original research article should contain completely new principal research testifying major contributions to the field. The study should represent new findings or discoveries in a subject area that were not published before. The report may contain significant findings, methodology importance and considerable evidence to the conclusions.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Perspective Article

Perspective article describes new or potentially unconventional point-of-views on existing clinical observations.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review Article

Review article is summarized descriptions of recent findings and significant developments at particular subject area of research considering the Journal’s scope. They should include critical assessments of novel technologies, evaluation of subject advancement, elucidate unresolved questions, comparative analysis with a substantial coverage of previous works and highlight future prospects. Although there are no restrictions with the length and content of a review, authors should consider drawing reader’s attention and interest with quality information.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Short Report

Short report is a helpful description on particular area of research confirming the results from previously published articles. The presentation should be in a way of extension to the previous research work with confirmatory results and evidences on negative results, clinical studies or even patients from a same family. Short report should provide the advancement in control to previous work. The basis and motivation for the work submitted as short report should be acknowledged.

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

All manuscripts submitted to the Trends in Immunotherapy are subjected to a stringent peer review process. This is to uphold the high quality of papers published in this journal and ensure that the reporting of research work is truthful and precise.

  1. All submitted manuscript are firstly handled by our managing editor, who will check the manuscript for plagiarism, in which rejection of the manuscript can take place at this stage by the managing editor if plagiarism occurs in the manuscript.
  2. After the plagiarism check is completed and results are deemed satisfactory, the managing editor will pass the manuscript to the Editor-in-Chief who will undertake the peer review process, or at times pass the task to one of the Associate Editors.
  3. A minimum of 2 reviewers will be selected from the pool of reviewers available according to their expertise and suitability to the subject matter of the manuscript. Reviewers will have to give their comments and recommendations (Accept, Revisions Required, Resubmit for Review or Reject) to the Editor-in-Chief or Associate Editor for them to make a final decision on the paper, and their comments will help the authors improve their papers.
  4. Upon recommendations by the reviewers, the Editor-in-Chief or the Associate Editor can make a final decision on the paper and inform the author on their decision, adding comments to the Authors to make improvements in their research or paper.
    • If the decision is to Accept Submission (no amendments required by author), the manuscript will be sent to the Editing stage.
    • If Editor-in-Chief suggests Revisions Required (minor revisions), authors are given a maximum of 2 weeks to revise and resubmit the article.
    • If Editor-in-Chief suggests Resubmit for Review (major revisions), authors are given a maximum of 4 weeks to revise and resubmit the article for the second round of review.
    • If the decision is to Reject Submission, the author will be notified and the rejected manuscript will be archived and the peer review process ends.
  5. An accepted paper will be sent for Copy Editing, Layout Editing and Proofreading before publication. Correspondence between the authors and editors will be required here in order to improve the language and/or look of the manuscript. After the Editing stage is completed, authors are required to check the PDF file of the final version before the article is published. EnPress Publisher registers DOI for the manuscript after publication, in which the article is immediately accessible to the public.
  6. Authors may appeal for a rejected submission. Appeal requests must be made in writing to contact@enpress-publisher.com with detailed reasons for the appeal and point by point responses to the reviewers’ remarks. Decisions on appeals are final and no further consideration will be made.

 

Open Access Policy

This journal provides immediate Open Access to its content as it believes that making research freely available to the public which helps promoting the research results benefiting the scholarly community.

  • Higher Visibility, Availability and Citations – free and unlimited accessibility of the publication over the internet without any restrictions increases citation of the article
  • Ease of search – publications are easily searchable in search engines and indexing databases
  • Rapid Publication – accepted papers are immediately published online

 

Editorial Policies

A manuscript would not be accepted if it has been published or is under consideration for publication in any other journal. The author also needs to notify the journal if the data presented in this paper has been ever presented in conferences.

After acceptance, the Publisher will have the right to edit the work for the original edition and for any revision.

 

Authorship

Authorship of a scholarly paper should be limited to individuals who have contributed substantially to its intellectual content. Participation solely in the acquisition of funding or general supervision of the research group is not sufficient for authorship. All authors should hold the responsibility of fairly evaluating their respective roles and their co-authors’ roles in the project. This is to ensure that authorship is attributed according to a fixed standard in all publications for which they will be listed as authors.

In order to be listed as an author for a paper, one should have contributed sufficiently in the project. A co-author is expected to have contributed to some component of the work which led to the paper, or be involved in interpretation of its results. All authors should have a say in the final approval of the version to be published, in addition to reviewing the final manuscript prior to submission.

Individuals who do not meet the above requirements, but have provided a valuable contribution to the work, may be acknowledged for their contribution as appropriate to the publication.

 

Publication Frequency

The publication frequency of Trends in Immunotherapy is quarterly.

 

Conflict of Interest

Conflicts of interest may exist when professional judgements concerning a primary interest has the possibility of being influenced by a secondary interest (e.g.: financial gains). It is to be noted that even perceptions of conflicts of interest are as important as the actual conflicts of interest.

Any agreements with study sponsors (for profit or non-profit), which interfere with the authors’ access to the study data, ability to analyse or interpret the data and publish manuscripts independently according to their own decision, should be avoided by authors at all costs.

A declaration of interests for all authors must be received before an article can be reviewed and accepted for publication.

 

Plagiarism

Authors are advised to perceive high standards in the aspect of publication ethics. Any plagiarism (fabrication or falsification of data) are strictly unacceptable practices in Trends in Immunotherapy, including duplicate publication of the author’s work without proper citation.

Every manuscript submitted for publication is checked for plagiarism via CrossCheck (powered by iThenticate) after submission and before being sent to the editor for editorial review. Any detection of overlapping and similar texts in the manuscripts submitted will be investigated promptly and may lead to the manuscript being rejected.

 

Article Processing Charges

The article processing charges are meant to support the journal’s associated expenses. The editorial team will have the right to assume that authors submitting their manuscripts for publication consents to paying the publication fee upon acceptance for publication.

Refer to http://enpress-publisher.com/journals/ti/apc/ for details.

 

Language

The language used in manuscripts submitted to Trends in Immunotherapy is English. Authors whose first language is not English may want to have their manuscripts professionally edited before the final submission to ensure that the academic content of the paper is fully understood by its prospective readers.

 

Permission and Reprints

Any part of materials published in Trends in Immunotherapy may not be reproduced without written permission of the publisher. Please click here to write in the permission request.








contact us

14701 Myford Road, Suite B-1, Tustin, CA 92780, United States
Tel:+1 (949) 299 0192